Eye Drops MAXIMUM, REDNESS RELIEF, Sterile, 1/2 FL OZ (0.5 ML); a) exchange select, Manufactured for your Military Exchange By: K.C Pharmac…
K.C. Pharmaceuticals, Inc. · Lack of Assurance of Sterility
- Status
- Ongoing
- City
- Pomona
- State
- CA
- Country
- United States
- Classification
- Class II
- Product type
- Drugs
- Event ID
- 99880
- Recalling firm
- K.C. Pharmaceuticals, Inc.
- Address 1
- 3420 Pomona Blvd
- Address 2
- N/A
- Postal code
- 91768-3236
- Voluntary mandated
- Voluntary: Firm initiated
- Initial firm notification
- Distribution pattern
- US Nationwide
- Recall number
- D-0005-2027
- Product quantity
- 1,435,830 cartons
- Reason for recall
- Lack of Assurance of Sterility
- Recall initiation date
- 20260911
- Center classification date
- 20261005
- Report date
- 20261014
- Product description
Eye Drops MAXIMUM, REDNESS RELIEF, Sterile, 1/2 FL OZ (0.5 ML); a) exchange select, Manufactured for your Military Exchange By: K.C Pharmaceuticals, Inc., Pomona, CA 9176, UPC: 6 14299 89636 9; b) Harris Teeter, PROUDLY DISTRIBUTED BY: HARRIS TEETER, LLC, MATTHEWS, NC 28105, UPC: 0 72036 73589 8; c) TYSON, MIKE RED EYE DROPS, Distributed by: JBRANDS Distribution, Miami, FL 33009, UPC: 7 84847 57549 4; d) up & up, Distributed by: Target Corporation, Minneapolis, MN 55403, NDC 11673-100-01; e) TopCare health, DISTRIBUTED BY TOPCO ASSOCIATES LLC, ELKGROVE VILLAGE, IL 60007, UPC 0 36800 21123 0; f) Walgreens, DISTRIBUTED BY: WALGREEN CO. 200 WILMOT RD, DEERFIELD, IL 60015, UPC 3 11917 20075 0.
- Code info
Lot: a) CM25E02, Exp.: 5/31/2027; CM25M01, Exp.: 10/31/2027; b) CM25E02, Exp.: 5/31/2027; c) CM25C01, Exp.: 3/31/2027; CM25C02, Exp.: 3/31/2027; CM25C03, Exp.: 3/31/2027; CM25E02, Exp.: 5/31/2027; CM25F01, Exp.: 6/30/2027; CM25A02, Exp.: 1/1/2027; CM25B01, Exp.: 2/28/2027; d) CM25B01, Exp.: 2/28/2027; CM25E01, Exp.: 5/31/2027; CM25E02, Exp.: 5/31/2027; CM25K01, Exp.: 9/30/2027; CM25M01, Exp.: 10/31/2027; e) CM25B01, Exp.: 2/28/2027; CM25F01, Exp.: 6/30/2027; CM25K01, Exp.: 9/30/2027; CM25M01, Exp.: 10/31/2027; f) CM25B01, Exp.: 2/28/2027; CM25E02, Exp.: 5/31/2027; CM25K01, Exp.: 9/30/2027; CM25M01, Exp.: 10/31/2027.
- Harmonized identifiers (openFDA)
- Application number
- M018
- Brand name
- TARGET EYE DROPS MAXIMUM REDNESS RELIEF EYE
- Generic name
- GLYCERIN, NAPHAZOLINE HYDROCHLORIDE
- Manufacturer name
- Target Corporation
- Product NDC
- 11673-100
- Product type
- HUMAN OTC DRUG
- Route
- OPHTHALMIC
- Substance name
- GLYCERIN, NAPHAZOLINE HYDROCHLORIDE
- RxCUI
- 1235200
- SPL ID
- 0cfa0b71-d377-fa73-e063-6294a90a390e
- SPL set ID
- 1b26cd3b-4a05-4623-b320-01f22b3106ff
- Package NDC
- 11673-100-01
- Is original packager
- true
- Nui
- N0000185370, N0000175629, N0000184306, N0000185001, M0000728, M0009417
- Pharm class epc
- Non-Standardized Chemical Allergen [EPC]
- Pharm class pe
- Increased Histamine Release [PE], Cell-mediated Immunity [PE], Increased IgG Production [PE]
- Pharm class cs
- Allergens [CS], Glycerol [CS]
- UNII
- PDC6A3C0OX, MZ1131787D
- Upc
- 614299896369, 072036735898, 784847575494, 036800211230, 311917200750